OMPI Related Analyst Ratings
-
Canaccord Adams Maintains a 'Buy' on Obagi Medical Products (OMPI); Raises PT
-
Brean Murray Downgrades St. Jude Medical (STJ) to Hold
-
Piper Jaffray Downgrades Obagi Medical Products (OMPI) to Neutral; Significant Upside From Current Estimates Limited
-
Baird Upgrades Obagi Medical Products (OMPI) to Outperform
-
Piper Jaffray Initiates Coverage on Obagi Medical Products (OMPI) with an Overweight; Attractive at Current Levels
-
Thomas Weisel Starts Obagi Medical (OMPI) at Market Weight
-
Brean Murray Initiates Coverage on Obagi Medical Products (OMPI) with Buy
-
Baird Downgrades Obagi Medical Products (OMPI) to Neutral
-
Susquehanna Downgrades Obagi Medical Products (OMPI) to Neutral
-
Stanford Starts Obagi Medical (OMPI) at Buy
-
Matrix USA Rating Changes 6/18
-
Roth Capital Starts Obagi Medical Products (OMPI) at Buy
-
Oppenheimer Upgrades Obagi Medical Products (OMPI) to Outperform
-
CIBC downgrades Obagi Medical Products (OMPI) to Sector Perform
-
Baird upgrades Obagi Medical Products (OMPI) to Outperform
-
Baird downgrades Obagi Medical Products (OMPI) to Neutral
Back to OMPI Stock Lookup
